ASP Isotopes Inc. Announces Proposed Secondary Listing on the Johannesburg Stock Exchange

Core Viewpoint - ASP Isotopes Inc. is proposing a secondary listing of its common stock on the Johannesburg Stock Exchange (JSE) while maintaining its listing on the Nasdaq Capital Market, aiming to enhance liquidity and diversify its shareholder base [1][3][4]. Company Overview - ASP Isotopes Inc. is an advanced materials company focused on developing technology and processes for isotope production, with a strong emphasis on healthcare and technology industries [6]. - The company employs proprietary Aerodynamic Separation Process (ASP technology) for isotope enrichment and has facilities in Pretoria, South Africa [6][7]. Strategic Rationale for JSE Listing - The JSE listing is expected to provide access to a deeper capital market, enhance liquidity for shareholders, and attract interest from South African institutional investors due to the company's local presence and specialized technologies [3][4]. - The company has a significant South African footprint, with 97% of its employees and all operating assets located in South Africa, highlighting its commitment to the local community [5]. Market Demand and Product Focus - There is a growing demand for isotopes such as Silicon-28 (Si-28) for quantum computing and various isotopes for emerging healthcare and green energy applications [7]. - ASP Isotopes plans to enrich isotopes for the nuclear energy sector using its developing Quantum Enrichment technology [6].